Cargando…

Pharmacogenetics of tacrolimus: ready for clinical translation?

Tacrolimus (Tac) exhibits an interindividual pharmacokinetic variability that affects the dose required to reach the target concentration in blood. Tac is metabolized by two enzymes of the cytochrome P450 family, CYP3A5 and CYP3A4. The effect of the CYP3A5 genotype on Tac bioavailability has been de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coto, Eliecer, Tavira, Beatriz, Suárez-Álvarez, Beatriz, López-Larrea, Carlos, Díaz-Corte, Carmen, Ortega, Francisco, Álvarez, Victoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089617/ https://www.ncbi.nlm.nih.gov/pubmed/25028625 http://dx.doi.org/10.1038/kisup.2011.14

Ejemplares similares

NKG2D and its ligands: active factors in the outcome of solid organ transplantation?
por: Suárez-Álvarez, Beatriz, et al.
Publicado: (2011)

Soluble Co-Signaling Molecules Predict Long-Term Graft Outcome in Kidney-Transplanted Patients
por: Melendreras, Susana G., et al.
Publicado: (2014)

A 3’-UTR Polymorphism in Soluble Epoxide Hydrolase Gene Is Associated with Acute Rejection in Renal Transplant Recipients
por: Gervasini, Guillermo, et al.
Publicado: (2015)

Defining a Methylation Signature Associated With Operational Tolerance in Kidney Transplant Recipients
por: Rodriguez, Ramon M., et al.
Publicado: (2021)

Functional polymorphisms in genes of the Angiotensin and Serotonin systems and risk of hypertrophic cardiomyopathy: AT1R as a potential modifier
por: Coto, Eliecer, et al.
Publicado: (2010)

Epigenetic modulation of the immune function: A potential target for tolerance
por: Suárez-Álvarez, Beatriz, et al.
Publicado: (2013)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
por: Brunet, Mercè, et al.
Publicado: (2022)

Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation
por: Yu, Meng, et al.
Publicado: (2018)

Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention
por: Baragaño Raneros, Aroa, et al.
Publicado: (2014)

Mutation analysis of the LCE3B/LCE3C genes in Psoriasis
por: Coto, Eliecer, et al.
Publicado: (2010)

Phenotypic characteristics of aged CD4(+) CD28(null) T lymphocytes are determined by changes in the whole‐genome DNA methylation pattern
por: Suarez‐Álvarez, Beatriz, et al.
Publicado: (2016)

The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant Recipients
por: Madsen, Mads Juul, et al.
Publicado: (2017)

Insights from pharmacogenetic studies of antidepressants
por: Mandelli, Laura
Publicado: (2010)

Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity
por: Cuesta-Llavona, Elías, et al.
Publicado: (2021)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

Demethylation of H3K9 and H3K27 Contributes to the Tubular Renal Damage Triggered by Endoplasmic Reticulum Stress
por: Diaz-Bulnes, Paula, et al.
Publicado: (2022)

The importance of tacrolimus in the treatment of allergic keratoconjunctivitis
por: Araujo, Georgia, et al.
Publicado: (2015)

BET Protein Inhibitor JQ1 Modulates Mitochondrial Dysfunction and Oxidative Stress Induced by Chronic Kidney Disease
por: Rayego-Mateos, Sandra, et al.
Publicado: (2023)

Pharmacogenetics and pharmacogenomics: practical applications in routine medical practice
por: Maitland-van der Zee, Anke-Hilse, et al.
Publicado: (2010)

Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine
por: Mlinarič-Raščan, Irena, et al.
Publicado: (2009)

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients
por: Moes, D. J. A. R, et al.
Publicado: (2015)

Comparison of the Impact of Pharmacogenetic Variability on the PK of Slow Release and Immediate Release Tacrolimus Formulations
por: van Gelder, Teun, et al.
Publicado: (2020)

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
por: Srinivas, Lekshmy, et al.
Publicado: (2021)

Pharmacogenetics of FAC chemotherapy side effects in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2015)

Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity
por: Saiz, Maria Laura, et al.
Publicado: (2021)

Correction to: Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS‑CoV‑2 infectivity
por: Saiz, Maria Laura, et al.
Publicado: (2021)

The FCGR2A rs1801274 polymorphism was associated with the risk of death among COVID-19 patients
por: López-Martínez, Rocío, et al.
Publicado: (2022)

Factors affecting the long-term response to tacrolimus in renal transplant patients: Pharmacokinetic and pharmacogenetic approach
por: Katsakiori, Paraskevi F., et al.
Publicado: (2010)

Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?
por: Palmirotta, Raffaele
Publicado: (2021)

A single-nucleotide polymorphism in the human p27(kip1 )gene (-838C>A) affects basal promoter activity and the risk of myocardial infarction
por: González, Pelayo, et al.
Publicado: (2004)

A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis
por: Vidal-Castiñeira, Jose Ramón, et al.
Publicado: (2016)

Novel approaches such as pharmacogenetics and liquid biopsies in tumor treatment in the era of personalized therapy
por: Kralickova, Milena, et al.
Publicado: (2014)

Divergent SARS-CoV-2-specific T cell responses in intensive care unit workers following mRNA COVID-19 vaccination
por: Salgado Del Riego, Estefanía, et al.
Publicado: (2022)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Pharmacogenetics in the Brazilian Population
por: Suarez-Kurtz, Guilherme
Publicado: (2010)

Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
por: Gómez, Juan, et al.
Publicado: (2020)

Usefulness of Pharmacogenetic Analysis in Psychiatric Clinical Practice: A Case Report
por: Franco-Martin, Manuel A., et al.
Publicado: (2018)

Bilineal inheritance of type 1 autosomal dominant polycystic kidney disease (ADPKD) and recurrent fetal loss
por: Peces, Ramón, et al.
Publicado: (2008)

Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis
por: Morgado-Pascual, José Luis, et al.
Publicado: (2022)

Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
por: Hattinger, Claudia Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rk2ig6rtib6iusek0ge2ve113m